COMMUNIQUÉS West-GlobeNewswire

HTG Introduces the HTG EdgeSeq Mouse miRNA Whole Transcriptome Assay, a Comprehensive Panel for miRNA Expression Analysis for use in Translational Medicine and Preclinical Studies

29/08/2018 - 14:00

TUCSON, Ariz., Aug. 29, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the pre- [...]

resTORbio to Present at Wells Fargo 2018 Healthcare Conference

29/08/2018 - 14:00

BOSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]

Melinta Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

29/08/2018 - 14:00

NEW HAVEN, Conn., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]

BrainStorm Cell Therapeutics to Provide Corporate Update at the H.C. Wainwright & Co 20th Annual Investor Conference

29/08/2018 - 14:00

NEW YORK and PETACH TIKVAH, Israel, Aug. 29, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today [...]

Corium to Present at the H. C. Wainwright 20th Annual Global Investment Conference

29/08/2018 - 13:30

MENLO PARK, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Kiniksa to Present Late-Breaking KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology

29/08/2018 - 13:30

HAMILTON, Bermuda, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing [...]

Neos Therapeutics to Present at the Wells Fargo Healthcare Conference

29/08/2018 - 13:30

DALLAS and FORT WORTH, Texas, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative [...]

Conatus Pharmaceuticals to Present at BioCentury NewsMakers Conference

29/08/2018 - 13:30

SAN DIEGO , Aug. 29, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today [...]

Intercept to Present at Upcoming Investor Conferences

29/08/2018 - 13:05

NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Aptose to Present at Upcoming Investor Conferences in September 2018

29/08/2018 - 13:05

SAN DIEGO and TORONTO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]

Calithera Biosciences to Participate in the Citi 13th Annual Biotech Conference and the Wells Fargo Healthcare Conference

29/08/2018 - 13:05

SOUTH SAN FRANCISCO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced [...]

BioCryst Pharmaceuticals to Present at the Baird Global Healthcare Conference

29/08/2018 - 13:00

RESEARCH TRIANGLE PARK, N.C., Aug. 29, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the company will present at the Baird Global Healthcare Conference in New York on [...]

Arcturus Therapeutics Announces Appointment of Ernst & Young LLP as the Company’s Independent Auditor

29/08/2018 - 13:00

SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (“Arcturus” or the “Company”) (NASDAQ: ARCT), a leading RNA medicines company, today announced that at the Company’s Annual General Meeting of [...]

Bellicum Pharmaceuticals to Participate in Two Healthcare Investor Conferences in September

29/08/2018 - 13:00

HOUSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Axovant to Present at Upcoming Investor Conferences

29/08/2018 - 13:00

BASEL, Switzerland, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXON) today announced that Pavan Cheruvu, M.D., chief executive officer, will participate in two upcoming investor conferences. Dr Cheruvu [...]

iTeos Therapeutics to Participate in Upcoming U.S. Conferences in September

29/08/2018 - 13:00

iTeos Therapeutics to Participate in Upcoming U.S. Conferences in September Gosselies, Belgium – August 29, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced [...]

Codexis to Present at Three Investment Conferences in September

29/08/2018 - 13:00

REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: H.C. [...]

Cyclacel Pharmaceuticals to Present at the 20th Annual H.C. Wainwright Global Investment Conference

29/08/2018 - 13:00

BERKELEY HEIGHTS, N.J., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]

Akcea Therapeutics to Present at the Wells Fargo Healthcare Conference

29/08/2018 - 13:00

CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc.(NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., today announced that management will present a company overview at the Wells Fargo [...]